Literature DB >> 11444920

Autoantibodies from mothers of children with congenital heart block downregulate cardiac L-type Ca channels.

Y Qu1, G Q Xiao, L Chen, M Boutjdir.   

Abstract

Congenital heart block (CHB) affects offspring of mothers with autoantibodies (positive IgG) to intracellular SSA/Ro and SSB/La ribonucleoproteins and is associated with high morbidity and mortality. Here, we show that maternal anti-Ro/La antibodies immunoreact with human fetal cardiomyocyte sarcolemma, recognize human L-type Ca channel alpha(1C)-protein and functionally inhibit expressed current in oocytes injected with alpha(1C) cRNA and Purkinje L-type Ca current. Furthermore, cardiac myocytes from pups born to SSA/Ro-immunized mice exhibited reduced L-type Ca current density. All together, the data establish that L-type calcium channel is a target for maternal antibodies and may provide a functional basis for the electrocardiographic abnormalities seen in infants with CHB. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444920     DOI: 10.1006/jmcc.2001.1379

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  13 in total

Review 1.  Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal / foetal dyad at risk.

Authors:  J P Buyon; R M Clancy; D M Friedman
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

2.  Rescue and worsening of congenital heart block-associated electrocardiographic abnormalities in two transgenic mice.

Authors:  Eddy Karnabi; Yongxia Qu; Salvatore Mancarella; Mohamed Boutjdir
Journal:  J Cardiovasc Electrophysiol       Date:  2011-02-25

Review 3.  Neonatal lupus.

Authors:  Antonio Brucato; Rolando Cimaz; Marco Stramba-Badiale
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

Review 4.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

Review 5.  Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population.

Authors:  Christine Capone; Jill P Buyon; Deborah M Friedman; William H Frishman
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

6.  Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.

Authors:  Renate Claus; Heiko Hickstein; Thomas Külz; Ute Lenschow; Doris Meiske; Andrea Kotitschke; Hans-Jürgen Thiesen; Peter Lorenz
Journal:  Rheumatol Int       Date:  2006-01-10       Impact factor: 2.631

7.  Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.

Authors:  A Hoxha; A Ruffatti; A Ambrosi; V Ottosson; M Hedlund; L Ottosson; M Anandapadamanaban; M Sunnerhagen; S-E Sonesson; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2016-09-13       Impact factor: 4.330

8.  Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs.

Authors:  Frank Fabris; Yuankun Yue; Yongxia Qu; Mohamed Chahine; Eric Sobie; Peng Lee; Rosemary Wieczorek; Xian-Cheng Jiang; Pier-Leopoldo Capecchi; Franco Laghi-Pasini; Pietro-Enea Lazzerini; Mohamed Boutjdir
Journal:  J Physiol       Date:  2016-07-26       Impact factor: 5.182

Review 9.  Congenital heart block: evidence for a pathogenic role of maternal autoantibodies.

Authors:  Aurélie Ambrosi; Marie Wahren-Herlenius
Journal:  Arthritis Res Ther       Date:  2012-04-26       Impact factor: 5.156

Review 10.  Pharmacologic Approach to Sinoatrial Node Dysfunction.

Authors:  Pietro Mesirca; Vadim V Fedorov; Thomas J Hund; Angelo G Torrente; Isabelle Bidaud; Peter J Mohler; Matteo E Mangoni
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-10-05       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.